Cardioprotective Effects of Rivaroxaban on Cardiac Remodeling After Experimental Myocardial Infarction in Mice

The authors apologize for the written mistakes in the Result section; previous line graphs in Figure 2 showed mean ± 2 standard error (SE). We corrected line graphs in Figure 2 with mean ± SE. Corrections are shown below.

Page 159, Figure 2

Figure 2.

Effect of rivaroxaban on left ventricular (LV) remodeling after myocardial infarction (MI). Changes in (A) LV end-diastolic diameter (LVDd), (B) LV systolic dimension (LVDs), (C) M-mode percent fractional shortening (%FS), (D) interventricular septum thickness in diastole (IVSTd), and (E) posterior LV wall thickness in diastole (PLWTd)assessed by echocardiography before and at days 1, 7 and 14 after MI in the rivaroxaban and vehicle groups (n=35/group). Data are mean ± standard error. *P<0.05 vs. vehicle.